Russia Has Earned $300M on Vaccine Exports

Russia Has Earned $300M on Vaccine Exports

Russia exported more than $300 million worth of vaccines in the first five months of the year, customs data shows — more than the entire value of vaccines sold in the previous three years combined, The Moscow Times reported.

The increase was driven by foreign sales of Russia’s flagship Sputnik V anti-coronavirus vaccine, with millions of doses shipped overseas to customers including Argentina, Kazakhstan, Belarus, Hungary and Serbia. 

The figure also includes sales of non-coronavirus vaccines — mainly shots against yellow fever and flu. But the Trade Ministry told the RBC business site that the large jump in sales was mainly due to Sputnik V exports. 

Russia has not revealed specific details on how much money it has made, or expects to make, from selling Sputnik V around the world.

In the whole of 2019, Russia exported $60 million of vaccines — a figure which grew in 2020 to $70 million. 

In the first five months of 2021, Moscow’s vaccine exports surged to a total of $304 million, according to customs data analyzed by RBC. That compares to just $10 million during the same period of 2020.

4250 views
We use cookies and collect personal data through Yandex.Metrica in order to provide you with the best possible experience on our website.